Skip to content
AgingNexus
☰ Menu
Open access · US-GOV via ClinicalTrials.gov Clinical trial

The Impact of a Polyphenol-Rich Supplement on Epigenetic and Cellular Markers of Immune Age

Authors not listed

Big Bold Health, PBC · 2022

Epigenetic alterations Human Randomized controlled trial
＋ Sign in to save

Abstract

This is a prospective, interventional, single-arm, open-label pilot study of 50 patients to evaluate the effect of a polyphenol-rich nutritional supplement on epigenetic and cellular markers of immune age.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-05-29 MST

Cite this

APA
Anonymous. (2022). The Impact of a Polyphenol-Rich Supplement on Epigenetic and Cellular Markers of Immune Age. <em>Big Bold Health, PBC</em>. https://clinicaltrials.gov/study/NCT05234203
Vancouver
Anonymous. The Impact of a Polyphenol-Rich Supplement on Epigenetic and Cellular Markers of Immune Age. Big Bold Health, PBC. 2022.
BibTeX
@misc{anon2022TheImp, title = {The Impact of a Polyphenol-Rich Supplement on Epigenetic and Cellular Markers of Immune Age}, author = {Anonymous}, journal = {Big Bold Health, PBC}, year = {2022}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings